Renaissance Capital logo

BFRI News

Dermatological drug spinoff Biofrontera Inc. prices IPO at $5, the low end of the range

BFRI

Biofrontera Inc., a spinoff of Biofrontera AG's commercialized dermatology portfolio, raised $18 million by offering 3.6 million units at $5, the low end of the range of $5 to $7. The company had planned to offer 3.1 million units. Each unit consists of one share of common stock and one warrant exercisable at the offer price.  ...read more

Dermatological drug spinoff Biofrontera ups deal size, adds warrants ahead of $19 million IPO

BFRI

Biofrontera, a spinoff of Biofrontera AG's commercialized dermatology portfolio, raised the proposed deal size for its upcoming IPO on Tuesday. The company also changed the offering from shares to units with warrants attached. Because the offering now contains warrants, Biofrontera is no longer eligible for tracking and will be excluded from Renaissance Capital's stats. ...read more

US IPO Week Ahead: Consumer issuers remain active as hot dogs headline an 11 IPO week

PTLO

Updated Monday, 10/18. 11 IPOs are slated to raise $2.0 billion led by restaurant chain Portillo’s (PTLO). The diverse group also features investment management software, water pipelines, coconut water, and crypto mining. Portillo’s (PTLO), known for its Chicago-style hot dogs, plans to raise $375 million at a $1.3 billion...read more

US IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week

GTLB

The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead. Software development platform GitLab (GTLB) plans to raise $598 million at a $9.4 billion market cap. This founder-led company provides an end-to-end DevOps platform to accelerate the software development cycle from weeks to minutes and enable rapid,...read more